890 related articles for article (PubMed ID: 23235605)
21. Polyunsaturated fatty acid supplementation for schizophrenia.
Joy CB; Mumby-Croft R; Joy LA
Cochrane Database Syst Rev; 2003; (2):CD001257. PubMed ID: 12804400
[TBL] [Abstract][Full Text] [Related]
22. Exercise therapy for fatigue in multiple sclerosis.
Heine M; van de Port I; Rietberg MB; van Wegen EE; Kwakkel G
Cochrane Database Syst Rev; 2015 Sep; 2015(9):CD009956. PubMed ID: 26358158
[TBL] [Abstract][Full Text] [Related]
23. Vitamin D supplementation for prevention of cancer in adults.
Bjelakovic G; Gluud LL; Nikolova D; Whitfield K; Krstic G; Wetterslev J; Gluud C
Cochrane Database Syst Rev; 2014 Jun; (6):CD007469. PubMed ID: 24953955
[TBL] [Abstract][Full Text] [Related]
24. Information provision for people with multiple sclerosis.
Köpke S; Solari A; Khan F; Heesen C; Giordano A
Cochrane Database Syst Rev; 2014 Apr; (4):CD008757. PubMed ID: 24752330
[TBL] [Abstract][Full Text] [Related]
25. Nutritional interventions for reducing gastrointestinal toxicity in adults undergoing radical pelvic radiotherapy.
Henson CC; Burden S; Davidson SE; Lal S
Cochrane Database Syst Rev; 2013 Nov; (11):CD009896. PubMed ID: 24282062
[TBL] [Abstract][Full Text] [Related]
26. Omega-3 fatty acids (from fish oils) for cystic fibrosis.
McKarney C; Everard M; N'Diaye T
Cochrane Database Syst Rev; 2007 Oct; (4):CD002201. PubMed ID: 17943770
[TBL] [Abstract][Full Text] [Related]
27. Vitamin D supplementation for prevention of mortality in adults.
Bjelakovic G; Gluud LL; Nikolova D; Whitfield K; Wetterslev J; Simonetti RG; Bjelakovic M; Gluud C
Cochrane Database Syst Rev; 2014 Jan; (1):CD007470. PubMed ID: 24414552
[TBL] [Abstract][Full Text] [Related]
28. Vitamin D supplementation for women during pregnancy.
De-Regil LM; Palacios C; Lombardo LK; Peña-Rosas JP
Cochrane Database Syst Rev; 2016 Jan; (1):CD008873. PubMed ID: 26765344
[TBL] [Abstract][Full Text] [Related]
29. Omega-3 Polyunsaturated Fatty Acid Supplementation to Prevent Arteriovenous Fistula and Graft Failure: A Systematic Review and Meta-analysis of Randomized Controlled Trials.
Viecelli AK; Irish AB; Polkinghorne KR; Hawley CM; Johnson DW; Mori TA; Pascoe EM; Strippoli GFM; Lok CE; Palmer SC
Am J Kidney Dis; 2018 Jul; 72(1):50-61. PubMed ID: 29395485
[TBL] [Abstract][Full Text] [Related]
30. Home fortification of foods with multiple micronutrient powders for health and nutrition in children under two years of age (Review).
De-Regil LM; Suchdev PS; Vist GE; Walleser S; Peña-Rosas JP
Evid Based Child Health; 2013 Jan; 8(1):112-201. PubMed ID: 23878126
[TBL] [Abstract][Full Text] [Related]
31. Nutritional supplements for people being treated for active tuberculosis.
Sinclair D; Abba K; Grobler L; Sudarsanam TD
Cochrane Database Syst Rev; 2011 Nov; (11):CD006086. PubMed ID: 22071828
[TBL] [Abstract][Full Text] [Related]
32. Omega 3 fatty acid for the prevention of cognitive decline and dementia.
Sydenham E; Dangour AD; Lim WS
Cochrane Database Syst Rev; 2012 Jun; (6):CD005379. PubMed ID: 22696350
[TBL] [Abstract][Full Text] [Related]
33. Omega-3 fatty acids for intermittent claudication.
Campbell A; Price J; Hiatt WR
Cochrane Database Syst Rev; 2013 Jul; (7):CD003833. PubMed ID: 23824785
[TBL] [Abstract][Full Text] [Related]
34. Dietary interventions (plant sterols, stanols, omega-3 fatty acids, soy protein and dietary fibers) for familial hypercholesterolaemia.
Malhotra A; Shafiq N; Arora A; Singh M; Kumar R; Malhotra S
Cochrane Database Syst Rev; 2014 Jun; 2014(6):CD001918. PubMed ID: 24913720
[TBL] [Abstract][Full Text] [Related]
35. A novel oral nutraceutical formula of omega-3 and omega-6 fatty acids with vitamins (PLP10) in relapsing remitting multiple sclerosis: a randomised, double-blind, placebo-controlled proof-of-concept clinical trial.
Pantzaris MC; Loukaides GN; Ntzani EE; Patrikios IS
BMJ Open; 2013; 3(4):. PubMed ID: 23599375
[TBL] [Abstract][Full Text] [Related]
36. The association of dietary intake and supplementation of specific polyunsaturated fatty acids with inflammation and functional capacity in chronic obstructive pulmonary disease: a systematic review.
Atlantis E; Cochrane B
Int J Evid Based Healthc; 2016 Jun; 14(2):53-63. PubMed ID: 26134547
[TBL] [Abstract][Full Text] [Related]
37. The Effects of Specific Omega-3 and Omega-6 Polyunsaturated Fatty Acids and Antioxidant Vitamins on Gait and Functional Capacity Parameters in Patients with Relapsing-Remitting Multiple Sclerosis.
Aristotelous P; Stefanakis M; Pantzaris M; Pattichis CS; Calder PC; Patrikios IS; Sakkas GK; Giannaki CD
Nutrients; 2021 Oct; 13(10):. PubMed ID: 34684661
[TBL] [Abstract][Full Text] [Related]
38. Dietary supplements for established atopic eczema.
Bath-Hextall FJ; Jenkinson C; Humphreys R; Williams HC
Cochrane Database Syst Rev; 2012 Feb; 2012(2):CD005205. PubMed ID: 22336810
[TBL] [Abstract][Full Text] [Related]
39. Polyunsaturated fatty acids (PUFAs) for children with specific learning disorders.
Tan ML; Ho JJ; Teh KH
Cochrane Database Syst Rev; 2016 Sep; 9(9):CD009398. PubMed ID: 27678554
[TBL] [Abstract][Full Text] [Related]
40. Enteral omega-3 fatty acid supplementation in adult patients with acute respiratory distress syndrome: a systematic review of randomized controlled trials with meta-analysis and trial sequential analysis.
Zhu D; Zhang Y; Li S; Gan L; Feng H; Nie W
Intensive Care Med; 2014 Apr; 40(4):504-12. PubMed ID: 24556914
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
